Kiniksa Pharmaceuticals: Q4 Earnings Insights

Kiniksa Pharmaceuticals KNSA reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Kiniksa Pharmaceuticals missed estimated earnings by 26.19%, reporting an EPS of $-0.53 versus an estimate of $-0.42.

Revenue was up $18.75 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.21 which was followed by a 19.01% increase in the share price the next day.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.